YOUR WORLD IS CHANGING

OUR COMMITMENT

REMAINS SOLID

In 2016more than ever, we commitin this way to accomplishmore together.

AT VETOQUINOL, WE ARE BUILDING THE FUTURE OF OUR LABORATORY ON THE TRUSTWORTHY RELATIONSHIPS WE HAVE WITH OUR PARTNERS, ON THE DEVELOPMENT OF EVERY SINGLE EMPLOYEE, AND ON OUR LONG-HELD BELIEF IN CONTINUOUS IMPROVEMENT. LAST YEAR WE LAUNCHED OUR NEW VISUAL IDENTITY, AND ITS NEW TAGLINE: ACHIEVE MORE TOGETHER. WE HAVE SIMPLY PUT INTO WORDS WHAT IT IS THAT HAS ALWAYS DRIVEN US.

All of our projects are guided by our values and our belief that ani-mal health is a key element of the future of our planet. Vetoquinol teams work every day to make both people and animals happier and healthier.

Together we can achieve more each day

Achieve More Together: innovating to provide customer satisfaction

In July 2015, our UpCard® product was given its European community market authorisation. This product was designed to bring real improvements to animal quality of life and to the daily life of pet owners. As well as being a source of pride for our teams, this innovative product is changing the way veterina-rians treat congestive heart failure in dogs.

Achieve More Together: closer to our customers, all around the world

We have set up a joint venture with the leading veterinary pharmaceutical laboratory in Japan. In order to launch our brand on the 9th largest animal health market in the world, we are joining forces with Zenoaq KK and pooling our expertise and our products.

Achieve More Together:making continuous improvements

Listening to and understanding the needs of our customers also translates into the continuous improvement of our products and services. The launch of Flexadin® in its soft chew presentation in 2015 is a living proof of this.

Achieve More Together: supporting links between veterinarians and their customers

With Vet Touch Atlas, we are enabling veterinarians to explain to pet owners and illustrate in a clear and straight-forward way, the various diseases that their pets may be suffering from.

A WORD FROM

THE CEOCONTENTS

ENGAGED BY OUR HISTORY

FROM PAST TO PRESENT P. 4-5

ENGAGED BY OUR VALUES

ACHIEVE MORE TOGETHER P. 6-7

ENGAGED BY OUR PRODUCT STRATEGY

GROWTH MOMENTUM P. 8-9

ENGAGED BY OUR CREATIVITY

A CULTURE OF INNOVATION P. 10-11

MORE THAN

2,000EMPLOYEES

E342,6 MIN 2015

Matthieu Frechin,

Chief Executive Officer

24COUNTRIES

130DISTRIBUTORS

IN THE WORLD

10TOPIS ONE OF THE

VETERINARYPHARMACEUTICAL

COMPANIES

3

This philosophy is epitomised in our products, in the relationships we create with our partners and between oursel-ves, colleagues from all four corners of the world. Every day, we are develo-ping products and tools which advance Animal Health, make the daily life of breeders and pet owners who care for these animals easier, and help veteri-narians carry out their work success-fully. With this in mind, the needs of our customers are always the starting point for our ideas.

Our tagline is a philosophy that is lived out every day in all our actions and in the way in which we think about our projects, improve our processes and develop our teams.

Graphic charter: McCann Healthcare • Adaptation and layout: Skerzo Marketing & Com-munication • Photo credits: Vetoquinol, Shutterstock, Samuel Carnovali, Thierry Kuntz, Thinkstock, McCann Healthcare • Publication director: Matthieu Frechin

ENGAGED BY OUR KNOW-HOW

FOCUS ON INDUSTRIAL PERFORMANCE P. 12-13

ENGAGED BY OUR CLOSENESS

CLOSER TO YOU P. 14-15

ACHIEVE MORE TOGETHER

HIGHLIGHTS IN 2015 P. 16-17

ENGAGED BY OUR FUTURE

ROBUST GOVERNANCE FOR LASTING SUCCESS P. 18

A CAPTIVATING STORYIt all began at a pharmacy in the town of Lure, in north-eastern France near the Swiss and German borders. Joseph Frechin drew on his entrepreneurial intuition: next to his dispensary he set up a business manufacturing pharma-ceutical specialities for people, under the name «Laboratoires biochimiques de l’Est». He then had the idea of using the antiseptic properties of oxyquin-oline to treat animals. The remedy, baptised Vétoquinol, quickly made a name for itself, and Joseph Frechin added a veterinary department to his laboratory.

By 1948, Vetoquinol had set up production and packaging facilities to meet demand. The catalogue included more than 80 products and by 1970, this figure had already risen to 250.

INTERNATIONAL DIMENSIONStepping up growth and increasing exports, Vetoquinol was generating 20% of its revenues outside France by the 1980s. It created its first subsidi-aries in the Netherlands, Ireland and Belgium.

Vetoquinol set up an office in China in 2004 and created a subsidiary in India in 2009, followed by another in

Brazil in 2011. It grew its international presence further in 2014 with its arrival in Australia and in 2015 a joint venture saw its entry into Japan. Today, with 130 distributors and a presence in 24 countries across four continents - Europe, North and South America, and Asia-Pacific - Vetoquinol has developed a genuinely international network with its 2,000 employees.

A SHARED PHILOSOPHYBalanced growth hinges on robust roots. Those roots have been central to the Vetoquinol spirit since the very beginning. The scientific, production, sales and administrative teams all share the same passion, energy and commitment. Each Vetoquinol employee, wherever they are in the world, is proud to contri-bute to the shared effort of enhancing animal health for the well-being of people and animals.

STRENGTHS FOR THE FUTURETo pursue its growth, Vetoquinol has taken the decision to remain an independent laboratory, free to make its own decisions and to take a long-term approach to investment and growth. Its human size and family shareholding structure lend it agility and rapidity.

VETOQUINOL FROM PAST

TO PRESENT

ENGAGED BY OUR HISTORY

Engaged by our history

Vetoquinol was founded in 1933 and went on to become a leading international player in animal health. Working for the protection and well-being of animals, Vetoquinol innovates, develops, manufactures and sells veterinary drugs and

non-medicinal products worldwide.

The Group today ranks in the top 10 of veterinary pharmaceutical laboratories. Amid an increasingly competitive international environment,

it is harnessing sustainability, development and independence in the pursuit of its human adventure.

4 5

ACHIEVE MORE TOGETHERFollowing on from the work we carried out on our brand, we created a new tagline: Achieve More Together. This tagline serves as a motto for our teams, as they place considerable importance on the principles of cohe-siveness and unity, as well as collabo-ration with our customers and partners.

A MEANINGFUL BRAND Vetoquinol is an independent and international veterinary pharma-ceutical laboratory that builds trustworthy relationships with all stakeholders in animal health across the globe, including veterinarians, livestock breeders and pet owners.

SOME TESTIMONIES OF OUR TERRITORY MANAGERS

“For me, the «Achieve more to-gether» tagline means that I am not alone when I’m in my car or when I’m out visiting a veterinary clinic.”

“It means that I’m an impor-tant part of a global company which is continuing to find innova-tive solutions for animal health.”

“It means that there’s a whole team of people on whom I can rely to provide me with the equipment, products, support and advice I need and without which I wouldn’t have anything to offer the clinics or - even worse - nothing to help the animals which need our help.”

“It means that I am making a contribution to enhancing the everyday work of vets and their teams so that they can take care of pets and the people who love them.”

“And as a vet, animal lover and pet owner myself, I am doing a job that I love. I am part of a huge team working to help animals live happier and healthier lives.“

ACHIEVE MORE TOGETHER

ENGAGED BY OUR VALUES

Vetoquinol’s new brand identity translates into words and pictures the company’s desire to develop the sustainable relationships of trust that we

have forged with veterinarians, livestock breeders and pet owners.

6 7

OPERATIONAL EXCELLENCEBy developing products which are more innovative and easier to use, our teams are contributing to improving the daily life of our customers and to improving animal health.

For our industrial teams, this means working together to become a model of efficiency and operational excel-lence in the pharmaceutical indus-try to serve our internal and external customers. Vetoquinol is recognised as an alternative to the major players in the animal health industry. In this way, its closeness and technical expertise give real added value to its relationships with its veterinary customers. To do this, the whole organisation focuses on its customers in order to enhance this closeness and grow its market share and thus ensure the continued existence of the company.

RENOWNED HUMAN VALUESThe values of our Group are brought to life through the «Achieve more together» philosophy. It encompasses achievement, growth and working as a team... For us to grow, we take particu-

lar care to ensure that we have teams of people who are motivated, constant-ly learning and - as a result - thriving. Today, employees stay with the Group for an average of 9 years and 40% of management positions are filled by promoting staff internally. At Vetoquinol, we achieve more together, by developing the talents of every single person.

PARTNERS AND CUSTOMERS WHO TRUST USAs a Group which has strong human values, where there are boundless opportunities for growth, Vetoquinol is also notable for its responsible use of antibiotics, prevention linked to biosecurity, and a genuine considera-tion for environmental issues. These «global citizen» attitudes also help to strengthen the trust our partners and customers have in us. Whether it’s to support a veterinarian who is deve-loping a new clinic, help a producer get the most out of a farm, or help a pet owner maintain a pet’s well-being by providing high-quality products, Vetoquinol’s promise is always the same: Achieve more together!

Dominique Derveaux,Director, Europe and North America

Engaged by our values

Achieve more together» means understanding the needs of the final users of our products and tailoring our offering to meet those needs.

Achieve more together» means developing our skills, our talents, our passion, our ideas and our dreams and working with our partners to make them a reality, so that animals will be healthier, and pet owners and live-stock breeders happier.

2 MAIN MARKETSVetoquinol relies on a clear and effec-tive organisation structure adapted to the two main animal health markets: livestock and pets. These two markets are distinguished by their marketing approaches and the needs of their final customers, namely livestock breeders and pet owners.

> Livestock

Increasing demand for animal pro-teins is spurring livestock profession-als worldwide to improve productiv-ity while fully ensuring the health of their animals. Be it in the production of milk, beef or pork, Vetoquinol with its veterinary network provides advice, products and services in response to the challenges faced by livestock professionals.

> For pets:

The pet segment is characterised by moderate growth in mature econo-mies and strong growth potential in countries with growing econo-mies. Commensurate with the unique emotional relationships between owners and their pets, Vetoquinol has developed products blending efficacy and ease of administration.

The specific offer proposed to each of these two markets is the result of team

work, involving country representa-tives liaising continuously with their customers and the Group functions.

4 STRATEGIC SPECIESTo optimise R&D and marketing, the Group focuses on four key species: dogs, cats, cattle and pigs.

RIGOROUS CHOICES IN PATHOLOGIES AND PRODUCTSVetoquinol specifies its future prod-ucts in line with market needs, trends, the intensity of the competition and the expectations of customers.

The offer for pets comprises anti- infection products; treatments for pain and inflammation, behaviour, urinary incontinence, liver diseas-es, cardio-nephrology, external and internal anti-parasitics; and care and hygiene products.

For livestock, major emphasis is placed on anti-infection products to address the main respiratory, digestive, loco-motor, reproductive and udder diseases, and on the corresponding anti-inflam-matory treatments. This offer is rounded off by a reproduction range and coun-try-specific products.

> Infectious diseases

Vetoquinol, a creator of innovative antibiotics, has established itself as a European leader in anti-infection products, promoting the rational use of antibiotics. Forcyl®, an anti-infec-tion treatment for livestock, highlights the Group’s commitment through the SISAAB (Singe Action Short Acting Antibiotic) concept, or how to effec-

tively fight against acute respiratory pathologies in cattle while minimising the risk of the development of bacteri-al resistance to antibiotics.

> Pain and inflammation

Vetoquinol proposes a comprehen-sive range of products to prevent and relieve pain. By contributing to animal well-being, the Group fulfils an ethical and therapeutic objective, as pain is known to have a damaging effect on health.

> Cardio-nephrology

Heart and kidney failure are respective-ly the most frequent chronic illnesses in elderly dogs and cats. In 2015, Vetoquinol launched Upcard®, a genuinely innovative medecine which changes how veterinarians treat congestive heart failure.

> Behaviour

In parallel, Vetoquinol has moved into pet stress management, a market having grown considerably in the last five years. An innovative, patented product, Zylkène® helps dogs and cats to cope with unusual and potentially disturbing situations.

> Reproduction

With the acquisition in 2014 of Bioniche Animal Health, a major player in reproduction, particu-larly in North America, Vetoquinol offers a complete range of products to support its customers from concep-tion through to birth. The Group is now one of the world leaders in this field, and this is primarily due to Folltropin®.

UNE DYNAMIQUE DE CROISSANCE

ENGAGED BY OUR PRODUCT STRATEGY

Engaged by our product strategy8 9

Vetoquinol is a partner to veterinarians, helping them to propose effective solutions to pet owners and livestock professionals. The Group responds

to today’s principle health problems and offers a range of increasingly effective products and services adapted continuously to changes

in customer needs.

GROWTH MOMENTUM

SOME OF OUR LEADING PRODUCTS

> For livestock:

Tolfédine®CS

> For pets:

Cefaseptin®

Clavaseptin®

PRAGMATIC ORGANISATIONAbout 150 employees are developing innovative products to meet market needs.

A LONG AND EXPENSIVE PROCESSThe development of a new drug requires time (on average five to ten years), the participation of multidisciplinary teams and major investments of between €3 million and €15 million. The process remains complex and uncertain, with just 5% of candidate projects becoming a drug in the long term.

TECHNOLOGICAL INNOVATION PROGRAMMEVetoquinol has implemented a “Tech-nological Innovation” program to envision numerous paths of innova-tion for projects underway. This forg-es a firmer understanding of efficacy, tolerance and observance.

The pharmaceutical technologies with highly innovative formulations devel-oped as part of this programme are applied to different galenic forms. They are applied both in products for livestock and for pets.

Through these technological advances, Vetoquinol is able to meet the needs of its customers by creating new- generation drugs featuring controlled release, improved bioavailability, and the concealed taste of active ingre-dients for enhanced palatability.

INNOVATION, A TEAM JOBThe Business Development Divi-sion, Research and Medical Division, Product Project Division, and Product Development Division... Each pro-ject is built in close collaboration by pluridisciplinary teams and a number of departments. All of these structures belong to the Scientific Department in order to ensure internal coherence and make it possible to unlock synergies. Team work is key to the Group’s success, one of its fundamental values, and vital to its long-term future.

The marketing of a drug hinges on receiving marketing authorisation (MA). Granted on the basis of an exhaustive file; MA proves that the product meets the requirements of the health authorities in terms of quality, safety and efficacy.

UNE DYNAMIQUE DE CROISSANCE

ENGAGED BY OUR CREATIVITY

Vetoquinol splits its R&D projects portfolio between incremental innovation, which aims to make improvements to existing products, and disruptive

innovations which lead to the creation of new technologies.

10 11

A CULTURE OF INNOVATION

Engaged by our creativity

THE MAIN PHASES OF VETERINARY DRUG DEVELOPMENT

9 12

3

456

7

8

Pharmacovigilance: collection and recording of any side effects

Product marketing

Marketing Authorisation(MA)

Industrialisation: synthesis and manufacture of the dosage form

Clinical evaluation: evaluation of efficacy

Pre-clinical development: toxicologicalstudies and demonstration of safety

Development of candidate medicines

Search for the active ingredient (molecules)

Design: target and disease selection and identification of new therapeutic approaches

Engaged by our know-how12 13

and the support functions are designed to structure this autonomy by giving managers the technical resources and training they need.

AGILITY EVERY DAYTo achieve this, we are injecting some dynamism into the approach of continuous improvement that is already in place by supplementing it with the principles and tools of lean manufac-turing, agility models in the industry. In this approach, the human factor is key to continuing improving our working and safety conditions, our skills and our personal development.

Vetoquinol is evolving into an organi-sation which has motivation, a desire to ask questions and re-evaluate the status quo, and the expertise and tools needed to drive transformation, which is effective in supporting the growth of the Group.

A CLEARLY DEFINEDSTRATEGYWe want to give our customers the most added value possible, while still making significant headway in terms of our competitiveness.

Simplifying our processes and making them visible and understandable will help us to deliver what matters to our customers more quickly and more cost efficiently, with the right level of quality, while still complying with our regulatory obligations.

Performance, decisions and actions are managed in the most transparent way possible, at the most operational level possible, where added value is created.

We want to foster decision making and the implementation of those decisions on the ground. The line management system

With nine industrial sites around the world and support functions spread throughout the Group, Vetoquinol produced 24 million units in 2015. Year after year, each site aims to adapt so that it can become a model of performance in its manufacturing procedures. In this way, each site is equipped to serve the geographi-cal areas in which it is located in the first instance, but is also able to serve the other parts of the world where Vetoquinol has a presence.

FOCUS ON INDUSTRIAL

PERFORMANCEStrengthened by its people, diverse cultures, organisation structure and

technologies, Vetoquinol’s Global Industrial and Quality Division is at the heart of the system. This Division is aiming to become a model of agility, efficiency

and operational excellence in the pharmaceutical industry to serve both its internal and external customers.

ENGAGED BY OUR KNOW-HOW

STRICT RESPECT OF STANDARDSThe production of drugs for animals is ensured in strict respect of increa-singly stringent pharmaceutical standards. The production sites are compliant with Manufacturing Best Practices. Through its commitment to national and international professional organisations, Vetoquinol anticipates changes in regulation so as to better adapt its production base.

ENGAGED BY OUR CLOSENESS

14 15

SIDE BY SIDE WITH PROFESSIONALSThe day-to-day relationship between Vetoquinol and and all actors of Animal Health goes beyond the products themselves. The Group partners with them in their daily work and brings them services to improve the care they provide for animals.

The Group’s strong ties with veterinar-ians and pet owners is also reflected in the educational tools that it makes available at clinics to help with the correct use of drugs. Through tech-nical training, sales arguments and prescription monitoring, the continuous improvement of practices is an ongoing priority for our veterinary delegates in the field.

Vetoquinol provides its partner distrib-utors with operational assistance in many different fields, including tech-nical and scientific training, logistics, purchasing and even advice on human resources for some of its partners. The Group is taking things further by providing value-generating initiatives aimed at developing and optimising its partners’ sales.

UNE DYNAMIQUE DE CROISSANCE

Vetoquinol, in continuous contact with its customers, works to adapt its products and services to their needs. Through its strong grassroots presence, the Group anchors its partnership with players in animal health with a view to

making continuous progress.

CLOSER TO YOU

BEING CLOSE TO OUR CUSTOMERS AND PARTNERS MEANS BEING ABLE TO SUPPORT THEM EVERY DAY.

Engaged by our closeness

CONNECTED WITH OUR CUSTOMERSThe digital tools change everyday life of people and even more the one of Vetoquinol customers. Many inno-vative projects are in development, including the client relation manage-ment tool, farm audit tools, websites and apps for owners, and connected collars. Since 2014, Vetoquinol has on an exclusive basis offered veterinarians the first iPhone ECG app.

Similarly, social networks are a key communication channel and tie in with the Group’s ambition to support its customers day after day.

Production sites Commercial entities

The new corporate website has been designed with this principle in mind, and it offers content which is tailored to all the various groups of people who visit our site (investors, researchers, journalists, people

interested in working for Vetoquinol, the general public) and which can be accessed in just a few clicks.

www.vetoquinol.com

VETOQUINOL’SWINNINGNEW IDENTITYVetoquinol won the Gold Medal at the Deauville Healthcare Communication Festival for its new insti-tutional campaign, deve-loped in collaboration with McCann Healthcare Agen-cy, in the «Communica-tion Corporate Branding» category.

Since 1933 we have been

a family owned company,

exclusively dedicated

to animal health.

To make efficient animal care

easier worldwide, we expand our

offer of innovative products and

services, and we remain true to

why customers choose us:

Our commitment to listen,

understand and deliver on your

needs, globally and locally.

vetoquinol.com

YOUR WORLD IS CHANGING

OUR COMMITMENT REMAINS SOLID

Since 1933 we have been a family owned company,

exclusively dedicated to animal health.

To make efficient animal care easier worldwide, we expand our offer of innovative products and services, and we remain true to why customers choose us:

Our commitment to listen, understand and deliver on your needs, globally and locally.

vetoquinol.com

YOUR WORLD IS CHANGINGOUR COMMITMENT REMAINS SOLID

Achieve more together

NOTRE PROXIMITE NOUS ENGAGE

16 17

PARIS MARATHONIn April, 29 Vetoquinol employees took part in the Paris Marathon. Several subsidiaries of the Group were represented: France, USA, United Kingdom, Poland and Mexico. Employees from the United King-dom and the USA were running to raise money for two charities. They all gave it everything they had and reached the finish line at the end of their 26.2 mile run.

ACHIEVE MORE TOGETHER

2015 HIGHLIGHTS

Since October, Vetoquinol has been marketing Permacyl® in Europe. Permacyl® is an injectable antibiotic from the penicillin family which is indicated for the treatment of mastitis in dairy cattle. This product is fully in line with the mastitis strategy by supplementing the Group’s product offering.

FIRST STEPS IN JAPANVetoquinol and Nippon Zenyaku Kogyo Co., Ltd., which operates under the trade name «Zenoaq», have ente-red into a joint venture agreement to develop, register and market a range of animal health products in Japan.

ACHIEVE MORE TOGETHERVetoquinol first launched its new identity among its employees: each subsidiary and each entity worked together to establish how it wanted to interpret this tagline practically within its teams.The internal launches also provided opportunities for get-togethers, unique creations and ever more productive discussions.

NEW EQUIPMENT FOR THE WATER PURIFICATION EQUIPMENTThe new «perozonation» equipment for the water purification plant at the Lure site was officially launched in September 2015.

Remaining true to its values of inno-vation, Vetoquinol is the first French veterinary pharmaceutical company to implement this kind of liquid waste treatment system, which is based on hydrogen peroxide and ozone.

UPCARD®

Vetoquinol is innovating in the field of cardiology with the launch of Upcard©, the first torasemide-based diuretic registered for veterinary use, thereby strengthening its product offering in the field of animal cardiology.

Heart disease is common in dogs and is becoming increasingly common as dogs are now living longer.

Most treatments must be adminis-tered several times a day and for the remainder of the animal’s life, and this causes considerable inconvenience to pet owners.

The launch of this product was accom-panied by training which has been given to our veterinary customers throughout the world.

“This new reference product is a valuable addition to our offering and is fully in line with the implementation of our strategy“.

Engaged by our future18

ENGAGED BY OUR FUTURE

ROBUST GOVERNANCE FOR LASTING SUCCESS

2016 sees Vetoquinol celebrating 10 years on the stock exchange This major event in the Group’s history has enabled it to establish standards of excellence

in terms of the quality and transparency of its financial information, a quality which can be seen being put into practice every year when the

Registration Document is drawn up to comply with the requirements of the financial markets. Vetoquinol’s Social and Environmental Reporting

is also part of this spirit of excellence and was thus ranked first by the GAIA* Index in 2014 and 2015.

Board of Directors

The Group has committed to a transpar-ent and demanding corporate govern-ance system based on the MiddleNext corporate governance code of listed companies.

The Board of Directors comprises eight members, three of whom are independent directors. The Board is chaired by Etienne Frechin, who was responsible for the operational man-agement of the Vetoquinol group for over thirty years. The Audit, Remuner-ation and Strategy Committees work to supplement the information of the Board members.

The Board of Directors meets as often as the interests of the company require, and at least four times a year.

Executive Committee

The Executive Committee, the unique management body, is chaired by Matthieu Frechin, Chief Executive Officer of Vetoquinol. It is responsible for the operational management of the Group and is assisted by eight members. The Executive Committee meets every

month. It undertakes all the actions necessary to the implementation of strategy. It is tasked with enhancing the value of the Group’s human resources. It sets operational objectives and de-termines the actions required to meet those objectives.

vetoquinol.com

VETOQUINOL STOCK MARKET PRICE SINCE IPO

45,00 €

40,00 €

35,00 €

30,00 €

25,00 €

20,00 €

15,00 €

10,00 €

5,00 €

20060,00 €

2007 2008 2009 2010 2011 2012 2013 2014 2015

* The Gaia index was established by EthniFinance in order to evaluate extra-financial information published by issuers, in a fine-tuned approach that takes environmental, social and governance issues into account. In particular, this index helps managers and analysts incorporate extra-financial issues into their analysis and investment decision processes.

YOUR WORLD IS CHANGINGOUR COMMITMENT REMAINS SOLID

Since 1933 we have been a family owned company,

exclusively dedicated to animal health.

To make efficient animal care easier worldwide, we expand our offer of innovative products and services, and we remain true to

why customers choose us:

Our commitment to listen, understand and deliver on your

needs, globally and locally.

www.vetoquinol.com

South Korea Vetoquinol Korea Co. Ltd 45 Eunbit-ro, Deogyang-gu, Goyang-si, Gyeonggi-do, South Korea (Zip code: 10477) Tel. +82 31 967 8853 webmaster@vetoquinolkorea.com www.vetoquinol.kr

Spain Vetoquinol Especialidades Veterinarias SAU Carretera de Fuencarral 24 Edificio Europa I Portal 3 - 2º 5 28108 Alcobendas - Madrid Tel. +34 91 490 37 92 marketing.espana@vetoquinol.com www.vetoquinol.es

Switzerland Vetoquinol AG Freiburgstr. 255 3018 Bern Tel. +41 31 818 56 56 info@vetoquinol.ch www.vetoquinol.ch

United Kingdom Vetoquinol UK Ltd - Vetoquinol House Great Slade Buckingham Industrial Park Buckingham - MK18 1PA Tel. +44 1280 814 500 office@vetoquinol.com www.vetoquinol.co.uk

United States Vetoquinol USA Inc. 4250 N. Sylvania Ave. Fort Worth, TX 76137 Tel. +1 817 529 7500 Toll free number +1 800 267 5707 customerserviceusa@vetoquinol.com www.vetoquinolusa.com

Australia Vetoquinol Australia Pty Ltd Unit 302/2, 6-12 Boronia Road Da Vinci Business Park Brisbane Airport, Qld 4008 Tel. 1800 032 355 sales.australia@vetoquinol.com www.vetoquinol.com.au

Austria Vetoquinol Österreich GmbH Zehetnergasse 24 1140 Wien Tel. +43 14 16 39 10 office@vetoquinol.at www.vetoquinol.at

Belgium Vetoquinol N.V. Kontichsesteenweg 42 2630 Aartselaar Tel. +32 3 877 44 34 info@vetoquinol-benelux.be www.vetoquinol.be

Brazil Vetoquinol Saude Animal Ltda. Rua Alcantara, 195 Vila Maria São Paulo – SP 02110-010 Tel. +55 11 3568-1111 faleconosco@vetoquinol.com www.vetoquinol.com.br Mairipora Industrial site/Site Industriel Tel. +55 11 4486 8999

Canada Vetoquinol N.-A. Inc. 2000 chemin Georges Lavaltrie, Québec, J5T 3S5 Tel. +1 450 586 48 22 Toll free number / Numéro sans frais 1-800-565-0497 info@vetoquinol.ca www.vetoquinol.ca Princeville Industrial Site / Site Industriel Tel. +1-819-364-3073 Belleville Industrial Site / Site Industriel Tel. +1-343-362-0551 Saint-Hyacinthe R&D Center / Centre R&D Tel. 1-450-586-4822

Czech Republic Vetoquinol s.r.o. Zámecnická 411 288 02 Nymburk Tel. +420 325 51 38 22 vetoquinol@vetoquinol.cz www.vetoquinol.cz

France Head office: Vetoquinol S.A. Magny-Vernois BP 189 70204 Lure cedex Tel. +33 3 84 62 55 55 vetoquinol@vetoquinol.com www.vetoquinol.com France Division 37 rue de la Victoire 75009 Paris Tel. +33 1 55 33 50 25 comm.france@vetoquinol.com www.vetoquinol.fr

Germany Vetoquinol GmbH Parkstrasse 10 88212 Ravensburg Tel. +49 751 35 953 0 info@vetoquinol.de www.vetoquinol.de

India Vetoquinol India Animal Health P. Ltd 801, SIGMA - 8th Floor Hiranandani Business Park, Technology Street, Powai - Mumbai - 400076 Tel. +91 22 6132 2609 headoffice.mumbai@vetoquinol.in www.vetoquinol.in

Ireland Vetoquinol Ireland Ltd Vetoquinol House - Great Slade Buckingham Industrial Park Buckingham - MK18 1PA Tel. +44 1280 814 500 office@vetoquinol.ie www.vetoquinol.co.uk

Italy Vetoquinol Italia s.r.l. Via Piana, 265 47032 Bertinoro (FC) Tel. +39 0543 462411 vetoquinol.italia@vetoquinol.com www.vetoquinol.it

Japan Vetoquinol Japan Saikon 1-13-26, Koriyama City, Fukushima JAPAN 963-8862 Mobile: +81-(0)80-6033-2740 Mobile: +33 (0)6 76 86 06 68

Mexico Vetoquinol de México S.A. de C.V. Mariano Escobedo # 748 5º Piso Int. 2 - Col. -Nueva Anzures Delegación Miguel Hidalgo México, D.F. C.P. 11590 Tel. +52.55.5262.7540 sclientes@vetoquinol.mx www.vetoquinol.mx

Netherlands Vetoquinol B.V. Postbus 3191 - 5203 DD’s Hertogenbosch Tel. +31 10 498 00 79 info@vetoquinol-benelux.be www.vetoquinol.nl

People’s Republic of China Vetoquinol Trading (Shanghai) Co, Ltd Room C - 1607, Floor 16, Block C No, 85, Lou Shan Guan Road Oriental International Plaza Chang Ning District Shanghai 200336 Tel. +86 21 52570660 www.vetoquinol.cn

Poland Vetoquinol Biowet Sp. z o.o. ul. Kosynierów Gdynskich 13-14 66-400 Gorzów Wlkp. Tel. +48 95 728 5500 info.pl@vetoquinol.com www.vetoquinol.pl

Portugal Vetoquinol Unipessoal LDA Rua Consiglieri Pedroso, nº 123 Edifício H Queluz de Baixo 2730-056 Barcarena Tel. +351 21 434 0300 info.portugal@vetoquinol.com www.vetoquinol.pt

Russia Moscow Representative Office of Vetoquinol SA Gorbunova street, 2 build.3 121596 Moscow Tel. +7 495 120 01 51 info.ru@vetoquinol.com www.vetoquinol.ru

Scandinavia Vetoquinol Scandinavia AB Box 9 - SE-265 21 Astorp Sweden Tel. +46 426 7603 info@vetoquinol-scandinavia.com www.vetoquinol-scandinavia.com

OUR COMMITMENT REMAINS SOLID